drugset / Trial / NCT07545564
A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine
RandomizedParallel-groupDouble-blindPrevention
Summary
Mucosal-specific sIgA antibody GMT;Evaluate the achievement of 2-fold and 4-fold increases in the geometric mean titer (GMT) of specific nasal mucosal sIgA antibodies after vaccination
Timeline
- Start
- 2026-04-09
- Primary completion
- 2026-04-23
- Completion
- 2026-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAIV | Vaccine | — | Intranasal |